138 related articles for article (PubMed ID: 1430469)
1. Mutant p53 expression in solar keratosis: an immunohistochemical study.
Sim CS; Slater S; McKee PH
J Cutan Pathol; 1992 Aug; 19(4):302-8. PubMed ID: 1430469
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical examination of tumor-suppressor gene p53 product and pyrimidine dimer in solar keratosis.
Taguchi M; Watanabe S; Sato Y; Kameya T; Munakata N; Ishihara K; Nakane PK; Hisatome H; Ikeda S
J Cancer Res Clin Oncol; 1993; 119(5):260-2. PubMed ID: 7680043
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer.
McGregor JM; Yu CC; Dublin EA; Levison DA; MacDonald DM
Br J Dermatol; 1992 Nov; 127(5):463-9. PubMed ID: 1467284
[TBL] [Abstract][Full Text] [Related]
4. Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin.
Taguchi M; Watanabe S; Yashima K; Murakami Y; Sekiya T; Ikeda S
J Invest Dermatol; 1994 Oct; 103(4):500-3. PubMed ID: 7930674
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M
J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in solar keratoses.
Park WS; Lee HK; Lee JY; Yoo NJ; Kim CS; Kim SH
Hum Pathol; 1996 Nov; 27(11):1180-4. PubMed ID: 8912828
[TBL] [Abstract][Full Text] [Related]
7. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.
Einspahr JG; Alberts DS; Warneke JA; Bozzo P; Basye J; Grogan TM; Nelson MA; Bowden GT
Neoplasia; 1999 Nov; 1(5):468-75. PubMed ID: 10933063
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p53 gene and Ha-ras gene are independent events in solar keratosis and squamous cell carcinoma.
Taguchi M; Tsuchida T; Ikeda S; Sekiya T
Pathol Int; 1998 Sep; 48(9):689-94. PubMed ID: 9778107
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
Onodera H; Nakamura S; Sugai T
Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
[TBL] [Abstract][Full Text] [Related]
10. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
Ren ZP; Pontén F; Nistér M; Pontén J
Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.
Nelson MA; Einspahr JG; Alberts DS; Balfour CA; Wymer JA; Welch KL; Salasche SJ; Bangert JL; Grogan TM; Bozzo PO
Cancer Lett; 1994 Sep; 85(1):23-9. PubMed ID: 7923098
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous squamocellular carcinoma--immunohistochemical aspects].
Iosep I; Ivan L; Cozma L; Petrescu Z
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):509-15. PubMed ID: 21495358
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of solar keratoses to squamous cell carcinoma.
Marks R; Rennie G; Selwood TS
Lancet; 1988 Apr; 1(8589):795-7. PubMed ID: 2895318
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
16. The nature of solar keratosis: a critical review in historical perspective.
Heaphy MR; Ackerman AB
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):138-50. PubMed ID: 10863242
[No Abstract] [Full Text] [Related]
17. p53 immunohistochemical expression in early posttransplant-associated malignant and premalignant cutaneous lesions.
Ferrándiz C; Fuente MJ; Fernández-Figueras MT; Bielsa I; Just M
Dermatol Surg; 1999 Feb; 25(2):97-101. PubMed ID: 10037511
[TBL] [Abstract][Full Text] [Related]
18. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses.
McGregor JM; Farthing A; Crook T; Yu CC; Dublin EA; Levison DA; MacDonald DM
J Am Acad Dermatol; 1994 May; 30(5 Pt 1):701-6. PubMed ID: 8176007
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of proliferation- and apoptosis-related markers in lentigo maligna and solar keratosis keratinocytes.
Feinmesser M; Tsabari C; Fichman S; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2003 Aug; 25(4):300-7. PubMed ID: 12876487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
